Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 10 | uM | 9 | 5000.00 | 2808.68 | 5247.00 | 7946.50 | 0.6603 | 0.5167 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 7677.00 | 7946.50 | 0.9661 | 0.9545 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 7661.00 | 7946.50 | 0.9641 | 0.9518 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7119.00 | 7946.50 | 0.8959 | 0.8587 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 6340.00 | 7946.50 | 0.7978 | 0.7205 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 5000.00 | 2808.68 | 8145.00 | 7946.50 | 1.0250 | 1.0332 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7817.00 | 7946.50 | 0.9837 | 0.9782 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 5000.00 | 2808.68 | 7532.00 | 7946.50 | 0.9478 | 0.9299 |
| BT-20 | Linsitinib | 1 | uM | 9 | 5000.00 | 2808.68 | 7173.00 | 7946.50 | 0.9027 | 0.8681 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7721.00 | 7946.50 | 0.9716 | 0.9620 | |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7909.00 | 7946.50 | 0.9953 | 0.9937 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 5000.00 | 2808.68 | 5317.00 | 7946.50 | 0.6691 | 0.5301 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 5000.00 | 2808.68 | 7158.00 | 7946.50 | 0.9008 | 0.8655 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 8026.00 | 7946.50 | 1.0100 | 1.0133 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 5000.00 | 2808.68 | 8313.00 | 7946.50 | 1.0461 | 1.0610 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 7960.00 | 7946.50 | 1.0017 | 1.0023 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 7744.00 | 7946.50 | 0.9745 | 0.9659 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 8131.00 | 7946.50 | 1.0232 | 1.0308 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 5000.00 | 2808.68 | 7998.00 | 7946.50 | 1.0065 | 1.0086 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 8076.00 | 7946.50 | 1.0163 | 1.0217 | |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 8031.00 | 7946.50 | 1.0106 | 1.0141 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 5000.00 | 2808.68 | 2646.00 | 7946.50 | 0.3330 | -0.0390 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 5000.00 | 2808.68 | 7583.00 | 7946.50 | 0.9543 | 0.9386 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 7974.00 | 7946.50 | 1.0035 | 1.0046 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 5000.00 | 2808.68 | 2393.00 | 7946.50 | 0.3011 | -0.1013 |